Fox J - Search Results

1

CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype.

Thornhill JP, Pace M, Martin GE, Hoare J, Peake S, Herrera C, Phetsouphanh C, Meyerowitz J, Hopkins E, Brown H, Dunn P, Olejniczak N, Willberg C, Klenerman P, Goldin R, Fox J, Fidler S, Frater J; CHERUB investigators. Thornhill JP, et al. Among authors: fox j. Mucosal Immunol. 2019 Sep;12(5):1212-1219. doi: 10.1038/s41385-019-0180-2. Epub 2019 Jun 25. Mucosal Immunol. 2019. PMID: 31239514 Free article.

2

HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound.

Scriba TJ, Zhang HT, Brown HL, Oxenius A, Tamm N, Fidler S, Fox J, Weber JN, Klenerman P, Day CL, Lucas M, Phillips RE. Scriba TJ, et al. Among authors: fox j. J Clin Invest. 2005 Feb;115(2):443-50. doi: 10.1172/JCI23084. J Clin Invest. 2005. PMID: 15668739 Free PMC article.

3

Sexual transmission of single human immunodeficiency virus type 1 virions encoding highly polymorphic multisite cytotoxic T-lymphocyte escape variants.

Milicic A, Edwards CT, Hué S, Fox J, Brown H, Pillay T, Drijfhout JW, Weber JN, Holmes EC, Fidler SJ, Zhang HT, Phillips RE. Milicic A, et al. Among authors: fox j. J Virol. 2005 Nov;79(22):13953-62. doi: 10.1128/JVI.79.22.13953-13962.2005. J Virol. 2005. PMID: 16254331 Free PMC article.

4

Ultrasensitive detection and phenotyping of CD4+ T cells with optimized HLA class II tetramer staining.

Scriba TJ, Purbhoo M, Day CL, Robinson N, Fidler S, Fox J, Weber JN, Klenerman P, Sewell AK, Phillips RE. Scriba TJ, et al. Among authors: fox j. J Immunol. 2005 Nov 15;175(10):6334-43. doi: 10.4049/jimmunol.175.10.6334. J Immunol. 2005. PMID: 16272285

5

Resistance to HIV drugs in UK may be lower in some areas.

Fox JM, Fidler S, Weber J. Fox JM, et al. BMJ. 2006 Jan 21;332(7534):179-80. doi: 10.1136/bmj.332.7534.179-c. BMJ. 2006. PMID: 16424507 Free PMC article. No abstract available.

6

Comparative potency of three antiretroviral therapy regimes in primary HIV infection.

Fidler S, Fraser C, Fox J, Tamm N, Griffin JT, Weber J. Fidler S, et al. Among authors: fox j. AIDS. 2006 Jan 9;20(2):247-52. doi: 10.1097/01.aids.0000200530.71737.75. AIDS. 2006. PMID: 16511418 Clinical Trial.

7

Prevalence of primary genotypic resistance in a UK centre: Comparison of primary HIV-1 and newly diagnosed treatment-naive individuals.

Fox J, Hill S, Kaye S, Dustan S, McClure M, Fidler S, Mackie NE. Fox J, et al. AIDS. 2007 Jan 11;21(2):237-9. doi: 10.1097/01.aids.0000247577.26375.ef. AIDS. 2007. PMID: 17197816

8

Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort.

Fidler S, Fox J, Touloumi G, Pantazis N, Porter K, Babiker A, Weber J. Fidler S, et al. Among authors: fox j. AIDS. 2007 Jun 19;21(10):1283-91. doi: 10.1097/QAD.0b013e3280b07b5b. AIDS. 2007. PMID: 17545704

9

Risk of HIV transmission in discordant partners.

Fox J, Fidler S. Fox J, et al. J HIV Ther. 2007 Jun;12(2):48-53. J HIV Ther. 2007. PMID: 17641573 Review. No abstract available.

10

Primary HIV infection: to treat or not to treat?

Fidler S, Fox J, Porter K, Weber J. Fidler S, et al. Among authors: fox j. Curr Opin Infect Dis. 2008 Feb;21(1):4-10. doi: 10.1097/QCO.0b013e3282f428bf. Curr Opin Infect Dis. 2008. PMID: 18192779 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,680 results

Search Page